Search Within

Martin Stuart Tallman

  1. "Human Oncology and Pathogenesis Program"
Formats
  1. Meeting Abstract (74)
  2. Journal Article (61)
  3. Research Letter (2)
  4. Book Section (1)
  5. Guidelines (1)
  6. Review (1)
Groups
  1. Adult Leukemia (140)
  2. Center for Hematologic Malignancies (140)
  3. Department of Medicine (140)
  4. GSK Faculty (140)
  5. Hematologic Malignancies, Division of (140)
  6. Human Oncology and Pathogenesis Program (140)

More Groups

People
  1. Ross Levine (131)
  2. Omar Abdel-Wahab (51)
  3. Maria Arcila (30)
  4. Eytan Stein (29)
  5. Minal Patel (24)
  6. Raajit Rampal (24)

More People

Years
  1. 2024 (1)
  2. 2023 (5)
  3. 2022 (7)
  4. 2021 (7)
  5. 2020 (13)
  6. 2019 (11)

More Years

Publications
  1. Blood (70)
  2. Haematologica (8)
  3. Blood Advances (6)
  4. Leukemia Research (6)
  5. Cancer Research (5)
  6. Cancer Discovery (4)

More Publications

Publishers
  1. American Society of Hematology (76)
  2. Nature Publishing Group (14)
  3. American Association for Cancer Research (9)
  4. Ferrata Storti Foundation (8)
  5. Cell Press (6)
  6. Elsevier Ltd (6)

More Publishers

Results (140)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • TGFβR-SMAD3 signaling induces resistance to PARP inhibitors in the bone marrow microenvironment
    Journal Article

    Le, B. V.; Podszywalow-Bartnicka, P.; Maifrede, S.; Sullivan-Reed, K.; Nieborowska-Skorska, M.; Golovine, K.; Yao, J. C.; Nejati, R.; Cai, K. Q.; Caruso, L. B.; more...
    Cell Reports (2020)

    Fulltext@MSK | Save
  • Erythroid/megakaryoblastic leukemia with TP53 and RUNX1 mutations frequently occurs in blast transformation of Philadelphia chromosome-negative myeloproliferative neoplasms: A single-institution experience with 56 cases
    Meeting Abstract

    Liu, Y.; Mata, D.; Baik, J.; Famulare, C.; Sigler, A.; Arcila, M.; Zhang, Y.; Dogan, A.; Tallman, M.; Levine, R.; more...
    Laboratory Investigation (2020)

    Fulltext@MSK | Save
  • Frequent RUNX1 and TP53 mutations in secondary acute myeloid leukemia with mixed phenotype
    Meeting Abstract

    Galera, P.; Baik, J.; Famulare, C.; Sigler, A.; Zhang, Y.; Arcila, M.; Dogan, A.; Tallman, M.; Levine, R.; Glass, J.; more...
    Laboratory Investigation (2020)

    Fulltext@MSK | Save
  • Acute leukemia with lineage infidelity: Mixed phenotype AML exhibits a distinct immunophenotype with clinical features overlapping mixed phenotype acute leukemia
    Meeting Abstract

    Kresch, M. P.; Xiao, W.; Menghrajani, K.; Famulare, C.; Patel, M. A.; Baik, J.; Roshal, M.; Levine, R. L.; Tallman, M. S.; Glass, J. L.
    Blood (2019)

    Fulltext@MSK | Save
  • De novo myelodysplastic syndromes in patients 20-50 years old characterized by frequent mutations in TP53 and transcription-related genes
    Meeting Abstract

    Epstein-Peterson, Z. D.; Spitzer, B.; McCarter, J.; McGovern, E.; Levine, R. L.; Tallman, M. S.
    Blood (2019)

    Fulltext@MSK | Save
  • Leukemia cell of origin influences p53 activity and therapeutic sensitivity via an Evi1-dependent mechanism
    Meeting Abstract

    Cai, S. F.; Chu, S.; Goldberg, A. D.; Parvin, S.; Koche, R.; Glass, J. L.; Stein, E. M.; Tallman, M. S.; Sen, F.; Famulare, C.; more...
    Blood (2019)

    Fulltext@MSK | Save
  • Therapy-related acute lymphoblastic leukemia is a distinct entity with adverse genetic features and clinical outcomes
    Journal Article

    Saygin, C.; Kishtagari, A.; Cassaday, R. D.; Reizine, N.; Yurkiewicz, I.; Liedtke, M.; Stock, W.; Larson, R. A.; Levine, R. L.; Tallman, M. S.; more...
    Blood Advances (2019)

    Fulltext@MSK | Save
  • Inhibition of the mutated c-KIT kinase in AML1-ETO–positive leukemia cells restores sensitivity to PARP inhibitor
    Journal Article

    Nieborowska-Skorska, M.; Paietta, E. M.; Levine, R. L.; Fernandez, H. F.; Tallman, M. S.; Litzow, M. R.; Skorski, T.
    Blood Advances (2019)

    Fulltext@MSK | Save
  • Oncologic therapy for solid tumors alters the risk of clonal hematopoiesis
    Meeting Abstract

    Bolton, K.; Ptashkin, R.; Braunstein, L.; Gao, T.; Devlin, S. M.; Kelly, D.; Coombs, C.; Patel, M.; Moarii, M.; Bernard, E.; more...
    Cancer Research (2019)

    Fulltext@MSK | Save
  • MSK-IMPACT Heme: Validation and clinical experience of a comprehensive molecular profiling platform for hematologic malignancies
    Meeting Abstract

    Ptashkin, R. N.; Benayed, R.; Ziegler, J.; Rema, A. B.; Sadowska, J.; Kiecka, I.; Ho, C.; Yao, J. J.; Moung, C.; Petrova-Drus, K.; more...
    Cancer Research (2019)

    Fulltext@MSK | Save